Hello again Researchondemand and thank you for your question.
I've assembled a digest of links to statistics related to what you
listed in your question.
According to the US Department of Health and Human Services,
approximately seven million people in the US suffer from GERD.
“At least 15 percent of adult patients who suffer from the symptoms of
GER treat themselves with antacids weekly. GERD has a higher
prevalence in Western countries, and is increased in adults over age
40. During pregnancy, up to 25 percent of women suffer daily from
heartburn symptoms. GERD has also been recently recognized to occur
more frequently in infants and children than previously known.”
http://www.continuingeducation.com/pharmacy/gerd/references.html#ref4
“Gastroesophageal reflux disease is a clinical disorder characterized
by the retrograde flow of gastric contents across an incompetent
gastroesophageal junction into the esophagus. The most common symptom
of GERD is heartburn. GERD is the most common gastrointestinal
pathology. In the United States alone, industry sources have estimated
that 21 million people, or over 7% of the population, suffer from
GERD. About 40% of the adults in the United States experience GERD at
least once a month (most frequently heartburn).”
Yahoo Business
http://biz.yahoo.com/bw/020820/202164_1.html
June Russell's Health Facts
“Some 60 to 70 million Americans suffer from digestive diseases, and
in a single year they spend $107 billion on drugs and antacids to
fight them. Pharmaceuticals, however, are not the answer. Interference
with digestion can lead to chronic fatigue, premature aging,
arthritis, poor skin and hair, toxicity, allergies and cancer. Alcohol
can change the colon's pH, destroying beneficial bacteria.
("Probiotics Balance Digestion and Improve Overall Health," July 2001)
“An estimated 19 million Americans suffer from (GERD)
gastro-esophogeal reflux disease, a condition in which stomach acid
regularly flows backward into the esophagus and can lead to difficulty
swallowing, chest pain, and perhaps even esophageal cancer. In some
cases chronic nausea can be a symptom of GERD. Drinking less alcohol
can lessen symptoms. (“When Nausea Signals Something Serious,” Tufts
University Health and Nutrition Letter, July 1997)”
“GERD affects 21 million in the U.S. (5-7%), says Dr. Barry Jaffin,
M.D., Mt. Sinai School of Medicine.(healthology.com, Nov. 2001)”
“There are 100 million consumers who suffer heartburn and acid
indigestion. (HealthCentral, Oct. 17, 2000)”
“Heartburn: More than 60 million American adults experience heartburn
at least once a month, about 25 million adults suffer from it daily.
Twenty-five percent of pregnant women have heartburn each day. Chronic
heartburn (GERD - short for anthropophagi reflux disease) has recently
been linked to serious diseases, including ulcer and cancer. Avoid
triggers, like alcohol, for heartburn. (“Heartburn,” Medicine
Guidebook, July 2000)”
http://www.jrussellshealth.com/alcdig.html
“Peptic ulcer disease, estimated to affect 4.5 million people in the
United States, is a chronic inflammation of the stomach and duodenum.
Peptic ulcer disease is responsible for substantial human suffering
and a large economic burden. Every year 4 million people report
missing approximately 6 days from work because of their ulcers.”
http://www.niddk.nih.gov/health/digest/pubs/overview/overview.htm
“It is estimated that more than 100 million people in America are
affected by some form of digestive system disease. That's more than
half of the U.S. population”
http://www.smartbodyz.com/digestive-system-disorders1.htm
Proton Pump Inhibitors
2001 Sales = 10.2 (US$ Billions)
21.9% Growth Year-Over-Year
Source: IMS Retail and Provider Perspective
IMS Health Website
http://www.imshealth.com/public/structure/dispcontent/1,2779,1341-1341-144055,00.html
AstraZeneca’s Prilosec -- used to treat acid reflux, ulcers, and other
gastrointestinal conditions -- was the leader in both 1999 and 2000,
but at $4.6 billion fell to second as AstraZeneca’s newer product,
Nexium, grew quickly.
2001 Sales
Prilosec 4.6 (US$ Billions)
Prevacid 3.6 (US$ Billions)
IMS Health Website
http://www.imshealth.com/public/structure/dispcontent/1,2779,1341-1341-144055,00.html
Market share for proton pump inhibitors (retail Dec 2001)
prilosec (omeprazole) 37%
nexium (esomeprazole) 18%
prevacid (lansoprazole) 26%
protonix (pantoprazole) 9%
Source:
Pharmacy Utilization Trends & Analysis
A Pharmacoeconomic Perspective
“PPI Rx Market Share by Point of Service”
PowerPoint Presentation - Slide 12
July 2001 and December 2001
http://www.tricare.osd.mil/conferences/2002/downloads/T802ColDanRemund.ppt
Additional information that may interest you:
Antiulcerants: top therapy class
http://www.inpharm.com/intelligence/ims101101.html
GERD Articles Archive
http://www.gerd.com/articles/article.htm
The Pink Sheet – Prosilec News
http://www.bamcoalition.org/News/Prilosec/10.29.01.htm
Search Criteria:
million people in the US suffer from gastric acid secretion disorders
million people in the US suffer from gerd
U.S. market for medications to treat for GERD million OR million
U.S. proton pump inhibitors market share
U.S. PPI market
U.S. PPI market size
Prisolec market share
Nexium market share
Prevacid market share
Protonix market share
Gerd medication sales +U.S.
Ger medication sales +U.S.
I hope this provides you with the information you are seeking.
Kind regards,
Bobbie7-ga |
,
0 Comments
)